Related Experiment Video
Updated: Jul 16, 2026

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay
Published on: October 20, 2018
In Situ SERS Monitoring of Membrane Protein Homo- and Hetero-Dimerizations at the Single-Cell Level
Chen Dong1,2, Xinyue Fang1, Tingxiao Wang1
1State Key Laboratory of Flexible Electronics (LoFE), Jiangsu Key Laboratory of Smart Biomaterials and Theragnostic Technology, Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing210023, China.
None:
Dimerization of cell membrane receptors governs essential cellular processes─including signal transduction, growth, proliferation, and apoptosis─yet precise discrimination between homo- and heterodimers remains a persistent technical challenge. To address this, we developed an in situ surface-enhanced Raman scattering (SERS) imaging strategy that integrates aptamer recognition, proximity ligation assay (PLA), rolling circle amplification (RCA), and SERS tags, enabling simultaneous monitoring of membrane protein homo- and heterodimerization dynamics at the single live-cell level. As a proof of concept, we used c-Met homodimerization on the cell membrane surface as a model to construct and validate the feasibility of the proposed SERS strategy for visual detection of c-Met homodimer on the cell membrane surface at the single-cell level, as well as the intercellular HGF/c-Met signaling pathway based on c-Met dimerization detection. Furthermore, by adapting this strategy to multiplexed detection, we achieved concurrent visualization of HER2-HER2 homodimers and HER2-HER3 heterodimers on intact cell membranes. Critically, this SERS methodology provides unprecedented insights into cancer cell-stromal cell communication through real-time tracking of HER2-HER3 heterodimerization on SK-BR-3 cells. Its capability to resolve transient protein interactions within native cellular microenvironments underscores broad utility in intercellular signaling network analysis, molecular diagnostics, and targeted therapy development.
